Andrew A F Hack's Net Worth
Andrew A F Hack's net worth is estimated to be at least $224,537,562.24 as of 11/08/2024. CoreStreet's estimation of Andrew A F Hack's net worth is based on their sale of stock and current holding of stock.
Andrew A F Hack is Director at Nuvalent Inc. They have executed at least 35 trades of stock as per SEC Form 4 filings. Their most recent trade was for 880,000 units of NUVL stock on 03/27/2024. Their biggest sale was on 03/27/2024 when they sold 880,000 units of Nuvalent Inc stock for $64,037,600.00. They typically trade 4 times per year.
Total value of insider buys:
- $53,407,686.27
Total value of insider sells:
- $171,129,875.97
Most recent insider trade:
- March 27, 2024
Andrew A F Hack's Insider Trading History
| Nuvalent Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 27, 2024 | Director | 880,000 | $72.77 | Sell | $64,037,600.00 |
| Dynavax Technologies Corporation | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 8, 2023 | Director | 1,500,000 | $14.39 | Sell | $21,585,000.00 |
June 14, 2023 | Director | 500,000 | $12.68 | Sell | $6,340,000.00 |
Dec. 6, 2022 | Director | 1,500,000 | $11.60 | Sell | $17,400,000.00 |
Aug. 27, 2021 | Director | 2,000,000 | $16.22 | Sell | $32,440,000.00 |
Aug. 9, 2021 | Director | 2,250,000 | $10.80 | Sell | $24,300,000.00 |
May 27, 2020 | Director | 1,000,000 | $4.84 | Buy | $4,840,000.00 |
| Mersana Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 2, 2022 | Director | 14,760 | $3.20 | Buy | $47,232.00 |
May 31, 2022 | Director | 80,759 | $3.28 | Buy | $264,889.52 |
May 25, 2022 | Director | 90,155 | $3.17 | Buy | $285,791.35 |
May 23, 2022 | Director | 15,599 | $3.35 | Buy | $52,256.65 |
May 20, 2022 | Director | 100,000 | $3.46 | Buy | $346,000.00 |
May 18, 2022 | Director | 211,268 | $3.35 | Buy | $707,747.80 |
May 16, 2022 | Director | 135,292 | $3.10 | Buy | $419,405.20 |
April 12, 2022 | Director | 598,086 | $4.18 | Buy | $2,499,999.48 |
Feb. 7, 2022 | Director | 1,136,363 | $4.42 | Buy | $5,022,724.46 |
Jan. 12, 2021 | Director | 250,000 | $18.36 | Buy | $4,590,000.00 |
Jan. 8, 2021 | Director | 100,000 | $18.39 | Buy | $1,839,000.00 |
April 7, 2020 | Director | 3,445,667 | $9.43 | Buy | $32,492,639.81 |
| Editas Medicine Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 4, 2019 | CFO | 6,895 | $21.39 | Sell | $147,484.05 |
Jan. 4, 2019 | CFO | 7,000 | $22.48 | Sell | $157,360.00 |
Nov. 23, 2018 | CFO | 5,284 | $28.15 | Sell | $148,744.60 |
Oct. 26, 2018 | CFO | 6,000 | $25.70 | Sell | $154,200.00 |
Sept. 28, 2018 | CFO | 8,000 | $32.08 | Sell | $256,640.00 |
Aug. 31, 2018 | CFO | 10,000 | $32.23 | Sell | $322,300.00 |
June 4, 2018 | CFO | 10,000 | $38.63 | Sell | $386,300.00 |
March 20, 2018 | CFO | 40,000 | $38.06 | Sell | $1,522,400.00 |
March 16, 2018 | CFO | 6,000 | $39.43 | Sell | $236,580.00 |
Feb. 16, 2018 | CFO | 18,000 | $34.21 | Sell | $615,780.00 |
Dec. 19, 2017 | CFO | 14,649 | $24.68 | Sell | $361,537.32 |
Dec. 15, 2017 | CFO | 5,000 | $24.31 | Sell | $121,550.00 |
Nov. 20, 2017 | CFO | 5,000 | $25.35 | Sell | $126,750.00 |
Nov. 17, 2017 | CFO | 5,000 | $24.81 | Sell | $124,050.00 |
Feb. 15, 2017 | CFO | 3,000 | $19.20 | Sell | $57,600.00 |
Jan. 11, 2017 | CFO | 15,000 | $19.20 | Sell | $288,000.00 |